A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Recurrent or Metastatic Solid Tumors

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Los Angeles Cancer Network, Los Angeles, California, United States

    Contact: Study coordinator (Principal Investigator)
  • Valkyrie Clinical Trials, Los Angeles, California, United States

  • Pih Health Hematology Medical Oncology, Whittier, California, United States

    Contact: Study coordinator (Principal Investigator)
  • Orchard Healthcare Research Inc., Skokie, Illinois, United States

    Contact: Study coordinator (Principal Investigator)
  • M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Principal Investigator)
  • NYU Langone Health, New York, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Icahn School of Medicine At Mount Sinai Prime, New York, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Clinical Research Alliance, Westbury, New York, United States

    Contact: Study coordinator (Principal Investigator)
  • Tn Gynecologic Oncology Group, Llc, Chattanooga, Tennessee, United States

    Contact: Study coordinator (Principal Investigator)
  • The West Clinic, Germantown, Tennessee, United States

    Contact: Study coordinator (Principal Investigator)
  • SCRI Oncology Partners, Nashville, Tennessee, United States

  • Texas Oncology - West Texas, Amarillo, Texas, United States

  • Texas Oncology, P.A., Dallas, Texas, United States

  • Texas Oncology Gulf Coast, Pearland, Texas, United States

  • University of Utah Hospitals & Clinics, Salt Lake City, Utah, United States

    Contact: Study coordinator (Principal Investigator)
  • Virginia Cancer Specialists, Fairfax, Virginia, United States

  • Wenatchee Hospitals and Clinics, Wenatchee, Washington, United States

    Contact: Study coordinator (Principal Investigator)
  • DIABAID, Buenos Aires, Argentina

    Contact: Study coordinator (Principal Investigator)
  • Hospital Aleman, Buenos Aires, Argentina

    Contact: Study coordinator (Principal Investigator)
  • Hospital Sirio Libanes, Caba, Argentina

    Contact: Study coordinator (Principal Investigator)
  • Centro Médico Austral, Ciudad Autonoma Buenos Aires, Argentina

  • Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata, Argentina

    Contact: Study coordinator (Principal Investigator)
  • Genesiscare North Shore Oncology, St Leonards, New South Wales, Australia

    Contact: Study coordinator (Principal Investigator)
  • Blacktown Hospital, Blacktown, Australia

  • St Vincent'S Hospital Sydney, Mount Kuring-Gai, Australia

    Contact: Study coordinator (Principal Investigator)
  • St John of God Subiaco Hospital, Subiaco, Australia

    Contact: Study coordinator (Principal Investigator)
  • Princess Alexandra Hospital, Woolloongabba, Australia

    Contact: Study coordinator (Principal Investigator)
  • Cliniques Universitaires Saint-Luc, Brussels, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Grand Hospital de Charleroi, Charleroi, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Universitair Ziekenhuis Gent, Ghent, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Uz Leuven, Leuven, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Chu de Liă Ge, Liège, Belgium

    Contact: Study coordinator (Principal Investigator)
  • Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Cepon - Centro de Pesquisas Oncolă"Gicas de Santa Catarina, Florianópolis, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho, Jaú, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Hospital São Lucas Da Pucrs, Porto Alegre, Brazil

    Contact: Study coordinator (Principal Investigator)
  • Biocenter, Concepción, Chile

    Contact: Study coordinator (Principal Investigator)
  • Ic La Serena Research, La Serena, Chile

    Contact: Study coordinator (Principal Investigator)
  • Centro Del Cancer UC, Santiago, Chile

    Contact: Study coordinator (Principal Investigator)
  • Clinica Redsalud Vitacura, Santiago, Chile

    Contact: Study coordinator (Principal Investigator)
  • James Lind Centro de Investigacion Del Cancer, Temuco, Chile

    Contact: Study coordinator (Principal Investigator)
  • Centre Léon Bérard, Lyon, Rhone, France

    Contact: Study coordinator (Principal Investigator)
  • Chu Besançon - Hôpital Jean Minjoz, Besançon, France

    Contact: Study coordinator (Principal Investigator)
  • Hopital Saint Andre, Bordeaux, France

  • Institut Bergonié, Bordeaux, France

  • Centre Georges François Leclerc, Dijon, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Régional Du Cancer de Montpellier, Montpellier, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Curie - Site de Paris, Paris, France

    Contact: Study coordinator (Principal Investigator)
  • CRLCC Eugene Marquis, Rennes, France

  • Ico - Site René Gauducheau, Saint-Herblain, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Claudius Regaud, Toulouse, France

    Contact: Study coordinator (Principal Investigator)
  • Institut Gustave Roussy, Villejuif, France

    Contact: Study coordinator (Principal Investigator)
  • Charită - Campus Charită Mitte, Berlin, Germany

    Contact: Study coordinator (Principal Investigator)
  • Vivantes Klinikum Neukoelln, Berlin, Germany

    Contact: Study coordinator (Principal Investigator)
  • Staedtisches Klinikum Dresden Standort Dresden-Friedrichstadt, Dresden, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitaetsklinikum Heidelberg, Heidelberg, Germany

    Contact: Study coordinator (Principal Investigator)
  • Slk-Kliniken Heilbronn Gmbh, Heilbronn, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitäres Krebszentrum Leipzig UCCL, UKL AöR, Leipzig, Germany

    Contact: Study coordinator (Principal Investigator)
  • Univ der Johannes GutenbergU, Mainz, Germany

    Contact: Study coordinator (Principal Investigator)
  • Universitätsklinikum Münster, Medizinische Klinik A, Münster, Germany

    Contact: Study coordinator (Principal Investigator)
  • Cork University Hospital, Cork, Ireland

    Contact: Study coordinator (Principal Investigator)
  • Mater Misericordiae University Hospital, Dublin, Ireland

    Contact: Study coordinator (Principal Investigator)
  • Tallaght University Hospital, Dublin, Ireland

    Contact: Study coordinator (Principal Investigator)
  • St Vincent'S University Hospital, Dublin, Ireland

    Contact: Study coordinator (Principal Investigator)
  • University Hospital Galway, Galway, Ireland

    Contact: Study coordinator (Principal Investigator)
  • Fondazione Del Piemonte Per L'Oncologia Irccs Candiolo, Candiolo, Italy

    Contact: Study coordinator (Principal Investigator)
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Azienda Socio Sanitaria Territoriale Niguarda (Grande Ospedale Metropolitano Niguarda), Milan, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy

    Contact: Study coordinator (Principal Investigator)
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy

    Contact: Study coordinator (Principal Investigator)
  • Istituto Clinico Humanitas, Rozzano, Italy

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital, Chūōku, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital East, Kashiwa, Japan

    Contact: Study coordinator (Principal Investigator)
  • The Cancer Institute Hospital of Jfcr, Kōtoku, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Shizuoka Cancer Center, Nagaizumi-cho, Japan

    Contact: Study coordinator (Principal Investigator)
  • Aichi Cancer Center Hospital, Nagoya, Japan

    Contact: Study coordinator (Principal Investigator)
  • Kindai University Hospital, Ōsaka-sayama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Saitama Cancer Center, Saitama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Medical Care & Research Sa de Cv, Mérida, Mexico

    Contact: Study coordinator (Principal Investigator)
  • Centro de Atenciă"N E Investigaciă"N Clă Nica En Oncologă A, Mérida, Mexico

    Contact: Study coordinator (Principal Investigator)
  • Cryptex Investigacion Clinica S.A. de C.V., México, Mexico

    Contact: Study coordinator (Principal Investigator)
  • Amsterdam Umc, Locatie Vumc, Amsterdam, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Universitair Medisch Centrum Groningen, Groningen, Netherlands

  • Radboudumc Nijmegen, Nijmegen, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Erasmus Medisch Centrum, Rotterdam, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Erasmus Medisch Centrum, Rotterdam, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • Umc Utrecht, Utrecht, Netherlands

    Contact: Study coordinator (Principal Investigator)
  • SPZOZ Szpital Uniwer w Krakowie, Krakow, Poland

  • Instytut MSF Sp. z o.o., Lodz, Poland

  • MRUK-MED i Spółka z ograniczoną odpowiedzialnością, Rzeszów, Poland

    Contact: Study coordinator (Principal Investigator)
  • Mazowiecki Szpital Wojewodzki W Siedlcach Sp Z O O, Siedlce, Poland

    Contact: Study coordinator (Principal Investigator)
  • Aidport Sp Z O.O., Skorzewo, Poland

    Contact: Study coordinator (Principal Investigator)
  • Instituto Portuguă S de Oncologia de Lisboa Francisco Gentil, Epe, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Fundação Champalimaud, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar Universitário de Lisboa Norte, Lisbon, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Centro Hospitalar Universitario de Santo Antonio, Porto, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Inst Portude Onco do Porto, Porto, Portugal

    Contact: Study coordinator (Principal Investigator)
  • Hospital Clinic de Barcelona, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • ICO l'Hospitalet - Hospital Duran i Reynals, Barcelona, Spain

  • Hospital Universitari Vall D'Hebron, Barcelona, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital General Universitario Gregorio Marañon, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Clínico San Carlos, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario 12 de Octubre, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario La Paz, Madrid, Spain

    Contact: Study coordinator (Principal Investigator)
  • Hospital Universitario Virgen Macarena, Seville, Spain

    Contact: Study coordinator (Principal Investigator)
  • China Medical University Hospital, Taichung, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Cheng Kung University Hospitalx, Tainan, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • National Taiwan University Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Taipei Veterans General Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Koo Foundation Sun Yat-Sen cancer center, Taipei, Taiwan

  • Tri-Service General Hospital, Taipei, Taiwan

    Contact: Study coordinator (Principal Investigator)
  • Gulhane Training and Research Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Gazi University Medical Faculty, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Ankara University Cebeci Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Ankara City Hospital, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Medipol Mega University Hospital, Istanbul, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)
  • Izmir Medicalpark Hospital, Izmir, Turkey (Türkiye)

    Contact: Study coordinator (Principal Investigator)